Net sales reached $118.5 million, a 12.1% increase year-over-year. Adjusted EBITDA rose 33.0% to $14.1 million, with margins expanding to 11.9%. The company reported a GAAP net loss of $6.8 million, primarily due to non-cash derivative mark-to-market losses. Adjusted net income was $1.0 million, or $0.02 per diluted share, compared to a $1.4 million loss in Q1 2025. Long-term strategic goals for 2030 are now expected to be achieved by 2029.